132 related articles for article (PubMed ID: 15081217)
1. In vitro and in vivo evaluation of a matrix-in-cylinder system for sustained drug delivery.
Mehuys E; Vervaet C; Gielen I; Van Bree H; Remon JP
J Control Release; 2004 Apr; 96(2):261-71. PubMed ID: 15081217
[TBL] [Abstract][Full Text] [Related]
2. Human bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire core.
Mehuys E; Remon JP; Korst A; Van Bortel L; Mols R; Augustijns P; Porter C; Vervaet C
J Control Release; 2005 Oct; 107(3):523-36. PubMed ID: 16055224
[TBL] [Abstract][Full Text] [Related]
3. Hot-melt extruded ethylcellulose cylinders containing a HPMC-Gelucire core for sustained drug delivery.
Mehuys E; Vervaet C; Remon JP
J Control Release; 2004 Feb; 94(2-3):273-80. PubMed ID: 14744479
[TBL] [Abstract][Full Text] [Related]
4. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
[TBL] [Abstract][Full Text] [Related]
5. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
Li CJ; Yu YL; Yang QM; Li Y; Zhang YH; Wang JY
Yao Xue Xue Bao; 2010 Sep; 45(9):1170-6. PubMed ID: 21351575
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
Quinten T; De Beer T; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
[TBL] [Abstract][Full Text] [Related]
7. Formulation development and human in vitro-in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin.
Turner S; Federici C; Hite M; Fassihi R
Drug Dev Ind Pharm; 2004 Sep; 30(8):797-807. PubMed ID: 15521326
[TBL] [Abstract][Full Text] [Related]
8. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride.
Gil EC; Colarte AI; Bataille B; Pedraz JL; Rodríguez F; Heinämäki J
Int J Pharm; 2006 Jul; 317(1):32-9. PubMed ID: 16584856
[TBL] [Abstract][Full Text] [Related]
9. Naproxen release from sustained release matrix system and effect of cellulose derivatives.
Sarfraz MK; Rehman NU; Mohsin S
Pak J Pharm Sci; 2006 Jul; 19(3):251-5. PubMed ID: 16935834
[TBL] [Abstract][Full Text] [Related]
10. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.
Kim MS; Kim JS; You YH; Park HJ; Lee S; Park JS; Woo JS; Hwang SJ
Int J Pharm; 2007 Aug; 341(1-2):97-104. PubMed ID: 17499949
[TBL] [Abstract][Full Text] [Related]
11. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices.
Nokhodchi A; Hassan-Zadeh D; Monajjem-Zadeh F; Taghi-Zadeh N
Acta Pharm; 2008 Jun; 58(2):151-62. PubMed ID: 18515225
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.
Limpongsa E; Umprayn K
AAPS PharmSciTech; 2008; 9(2):464-70. PubMed ID: 18431661
[TBL] [Abstract][Full Text] [Related]
14. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation.
Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC; Takayama K
Eur J Pharm Biopharm; 2004 Nov; 58(3):607-14. PubMed ID: 15451535
[TBL] [Abstract][Full Text] [Related]
15. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
Ige PP; Gattani SG
Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196
[TBL] [Abstract][Full Text] [Related]
16. [Preparation of verapamil hydrochloride controlled-onset extended-release pellets and its pharmacokinetics in dogs].
Chen ZP; Xiao YY; Chen HX; Chen XJ; Li LR; Zhu JB
Yao Xue Xue Bao; 2006 Aug; 41(8):765-71. PubMed ID: 17039785
[TBL] [Abstract][Full Text] [Related]
17. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
18. Preparation of extended release solid dispersion formulations of tacrolimus using ethylcellulose and hydroxypropylmethylcellulose by solvent evaporation method.
Tsunashima D; Yamashita K; Ogawara K; Sako K; Higaki K
J Pharm Pharmacol; 2016 Mar; 68(3):316-23. PubMed ID: 26773717
[TBL] [Abstract][Full Text] [Related]
19. Sustained-release and swelling characteristics of xanthan gum/ethylcellulose-based injection moulded matrix tablets: in vitro and in vivo evaluation.
Quinten T; De Beer T; Onofre FO; Mendez-Montealvo G; Wang YJ; Remon JP; Vervaet C
J Pharm Sci; 2011 Jul; 100(7):2858-70. PubMed ID: 21254067
[TBL] [Abstract][Full Text] [Related]
20. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization.
Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
Int J Pharm; 2007 Mar; 333(1-2):136-42. PubMed ID: 17207943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
